Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S152
DOI: 10.1016/j.ijrobp.2026.06.237 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von Z. Zeng und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zeng, Z., Yan, J., Hu, K., & Zhang, F. (2026). Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study. International Journal of Radiation Oncology*Biology*Physics, 126(1), S152. https://doi.org/10.1016/j.ijrobp.2026.06.237
Vancouver
Zeng Z, Yan J, Hu K, Zhang F. Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S152. doi:10.1016/j.ijrobp.2026.06.237
BibTeX
@article{Zeng2026,
author = {Zeng, Z. and Yan, J. and Hu, K. and Zhang, F.},
title = {Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S152},
doi = {10.1016/j.ijrobp.2026.06.237}
}
EUVIMED